Analysts think ARMP stock price could increase by 223%
Sep 25, 2024, 6:26 AM
8.14%
What does ARMP do
Armata Pharmaceuticals is a clinical-stage biotechnology company based in Los Angeles, focusing on bacteriophage therapeutics for drug-resistant infections, employing 66 staff. Its lead candidates target Pseudomonas aeruginosa and Staphylococcus aureus infections.
3 analysts think ARMP stock price will increase by 223.08%. The current median analyst target is $7.14 compared to a current stock price of $2.21. The lowest analysts target is $7.07 and the highest analyst target is $7.35.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
